A report on older‐age bipolar disorder from the International Society for Bipolar Disorders Task Force

M Sajatovic, SA Strejilevich, AG Gildengers… - Bipolar …, 2015 - Wiley Online Library
Objectives In the coming generation, older adults with bipolar disorder (BD) will increase in
absolute numbers as well as proportion of the general population. This is the first report of …

Carnitine in the treatment of valproic acid-induced toxicity

PER Lheureux, P Hantson - Clinical Toxicology, 2009 - Taylor & Francis
Introduction. Valproic acid (VPA) is a broad-spectrum antiepileptic drug that is now used
commonly for several other neurological and psychiatric indications. VPA is usually well …

Ammonia metabolism and hyperammonemic disorders

V Walker - Advances in clinical chemistry, 2014 - Elsevier
Human adults produce around 1000 mmol of ammonia daily. Some is reutilized in
biosynthesis. The remainder is waste and neurotoxic. Eventually most is excreted in urine as …

Valproic acid-induced encephalopathy: A review of clinical features, risk factors, diagnosis, and treatment

J Wu, J Li, W Jing, X Tian, X Wang - Epilepsy & Behavior, 2021 - Elsevier
Valproic acid (VPA), or sodium valproate, is a commonly used medication for seizure
disorders, migraines, and mental illness. Although VPA is relatively safe, it still has several …

[HTML][HTML] Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy

H Cichoż-Lach, A Michalak - World journal of gastroenterology …, 2013 - ncbi.nlm.nih.gov
Hepatic encephalopathy is a medical phenomenon that is described as a neuropsychiatric
manifestation of chronic or acute liver disease that is characterized by psychomotor …

Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management

A Chopra, BP Kolla, MP Mansukhani, P Netzel… - General hospital …, 2012 - Elsevier
INTRODUCTION: Valproate (VPA)-induced hyperammonemic encephalopathy (VHE) is a
serious drug-related adverse effect characterized by lethargy, vomiting, cognitive slowing …

Alcohol withdrawal syndrome in neurocritical care unit: assessment and treatment challenges

S Farrokh, C Roels, KA Owusu, SE Nelson, AM Cook - Neurocritical care, 2021 - Springer
Alcohol withdrawal syndrome (AWS) can range from mild jittery movements, nausea,
sweating to more severe symptoms such as seizure and death. Severe AWS can worsen …

Severe hyperammonaemia in adults not explained by liver disease

V Walker - Annals of Clinical Biochemistry, 2012 - journals.sagepub.com
Ammonia is produced continuously in the body. It crosses the blood–brain barrier readily
and at increased concentration it is toxic to the brain. A highly integrated system protects …

Valproate-induced hyperammonemic encephalopathy: a brief review

C Lewis, A Deshpande, GE Tesar… - Current medical research …, 2012 - Taylor & Francis
Background: This brief review presents a comprehensive evaluation of valproate-induced
encephalopathy (VHE) and also discusses potential mechanisms of the condition. Scope …

Valproic Acid–Associated Hyperammonemia: A Systematic Review

YCJ Wong, J Fan, A Wan, T Mihic… - Journal of Clinical …, 2023 - journals.lww.com
Background Hyperammonemia is an adverse effect that poses clinical uncertainty around
valproic acid (VPA) use. The prevalence of symptomatic and asymptomatic …